Zhejiang Hisun Pharmaceutical Co Ltd (600267) — Cash Flow Quality Index
Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Cash Flow Quality Index of 2.71x as of September 2025. Operating cash flow of CN¥438.43 Million exceeds net income of CN¥161.86 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Zhejiang Hisun Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Hisun Pharmaceutical Co Ltd Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Zhejiang Hisun Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 600267 cash flow metrics.
Annual Cash Flow Quality Index for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)
Year-by-year earnings quality comparison for Zhejiang Hisun Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.76x | CN¥2.03 Billion | CN¥540.71 Million | ▲ +5.1% |
| 2024 | 3.58x | CN¥2.11 Billion | CN¥591.31 Million | ▼ -14.9% |
| 2022 | 4.20x | CN¥2.07 Billion | CN¥491.42 Million | ▲ +23.6% |
| 2021 | 3.40x | CN¥1.74 Billion | CN¥510.63 Million | ▲ +54.7% |
| 2020 | 2.20x | CN¥1.59 Billion | CN¥723.17 Million | ▲ +1.7% |
| 2019 | 2.16x | CN¥698.39 Million | CN¥323.27 Million | ▼ -59.7% |
| 2017 | 5.36x | CN¥1.24 Billion | CN¥231.57 Million | ▼ -57.3% |
| 2016 | 12.54x | CN¥775.90 Million | CN¥61.85 Million | ▲ +115.2% |
| 2015 | 5.83x | CN¥736.17 Million | CN¥126.30 Million | ▲ +463.4% |
| 2014 | 1.03x | CN¥571.04 Million | CN¥551.97 Million | ▼ -0.4% |
| 2013 | 1.04x | CN¥527.25 Million | CN¥507.52 Million | ▼ -25.6% |
| 2012 | 1.40x | CN¥375.75 Million | CN¥269.05 Million | ▲ +37.0% |
| 2011 | 1.02x | CN¥525.31 Million | CN¥515.45 Million | ▼ -25.1% |
| 2010 | 1.36x | CN¥509.18 Million | CN¥374.35 Million | ▼ -19.8% |
| 2009 | 1.70x | CN¥472.85 Million | CN¥278.70 Million | ▲ +53.9% |
| 2008 | 1.10x | CN¥221.28 Million | CN¥200.69 Million | ▼ -64.0% |
| 2007 | 3.06x | CN¥437.72 Million | CN¥142.83 Million | ▲ +131.0% |
| 2006 | 1.33x | CN¥108.03 Million | CN¥81.43 Million | ▲ +38.7% |
| 2005 | 0.96x | CN¥113.53 Million | CN¥118.68 Million | ▼ -33.1% |
| 2004 | 1.43x | CN¥312.93 Million | CN¥218.79 Million | ▼ -13.7% |
| 2003 | 1.66x | CN¥288.45 Million | CN¥174.08 Million | ▼ -27.8% |
| 2002 | 2.30x | CN¥120.82 Million | CN¥52.63 Million | ▲ +63.0% |
| 2001 | 1.41x | CN¥69.14 Million | CN¥49.07 Million | ▲ +39.3% |
| 2000 | 1.01x | CN¥55.70 Million | CN¥55.09 Million | ▲ +55.3% |
| 1999 | 0.65x | CN¥32.64 Million | CN¥50.15 Million | — |